Innovation in Drug Discovery:
a new role for Basic Research and Academia

IFOM-IEO Campus, Milan, Italy
30th March 2010

h. 14.00/14.30 - Registration

h. 14.30/14.35 - Opening remarks

h. 14.35/15.00 - John McCall
Translational R&D in Academia and Industry: A Changing Environment

h. 15.00/15.25 - Giulio F. Draetta
From cancer target discovery to cures in an academic setting

h. 15.25/15.50 - Mario Varasi
The Drug Discovery Program at IEO

h. 15.50/16.10 - Coffee break

h. 16.10/16.35 - Steve Jackson
The DNA-damage response: new molecular insights and new approaches to cancer therapy

h. 16.35/17.00 - Stephen Hanessian
Vorinostat-like molecules as structural, stereochemical, and pharmacological tools

h. 17.00/17.25 - Saverio Minucci
Mitochondrial medicine: the permeability transition pore as a drug target for aging-associated diseases

h. 17.25/17.50 - Pier Paolo Di Fiore/Pier Giuseppe Pelicci
Cancer stem cells: a new target for drug discovery

Download area: